Grants & Projects per year
Personal profile
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
WEP Clinical: Emalex Biosciences, Inc - EBS-101-TD-392, An Open Label Expanded Access Program Intended to Provide Treatment with Ecopipam (EBS-101) to Children, Adolescents and Adults in the U.S. with Tourette's Disorder
Maurer, C. (PI) & Schwartz, G. (CoPI)
Emalex Biosciences Incorporated
05/8/26 → 11/14/26
Project: Research
-
Thomas Hartman Center for Parkinson's Research
Fontanini, A. (PI), Bowen, M. E. (CoI), Collins III, W. (CoI), Colognato, H. (CoI), Hu, C.-K. (CoI), Kritzer, M. (CoI), Lamberg, E. M. (CoI), Leung, H. C. (CoI), Maffei, A. (CoI), Maurer, C. (CoI), Muratori, L. M. (CoI), Neiman, A. (CoI), Plotkin, J. (CoI), Puopolo, M. (CoI), Riessland, M. (CoI), Schwartz, G. (CoI), Shelly, M. (CoI), Sher, R. (CoI), Shrestha, P. (CoI), Sirotkin, H. I. (CoI), Solomon, I. C. (CoI), Thomsen IV, G. H. (CoI), Wollmuth, L. (CoI), Wu, S. (CoI), Xiong, Q. (CoI), Role, L. (PI), Christodoulou, C. (CoI), Evinger, L. (CoI), Halegoua, S. (CoI), Huang, C. (CoI), Levine, J. (CoI), Lutterbie, J. (CoI), Manganas, L. (CoI), Matthews, G. (CoI), Park, I. M. (CoI) & Talmage, D. (CoI)
04/15/13 → 08/31/27
Project: Research
-
Emalex Biosciences: A Multicenter, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Maintenance of Efficacy of Ecopipam in Children, Adolescents and Adults with Tourette's Disorder
Maurer, C. (PI), Schwartz, G. (CoPI) & Swain, J. (CoPI)
08/1/24 → 07/24/26
Project: Research
-
Stress Management and Resiliency Training in People with Parkinson's Disease and their Care Partners
Maurer, C. W., Skinner, S., Kulikov, V. N. & Gonzalez, A., 2026, (Accepted/In press) In: Movement Disorders Clinical Practice.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
True vignettes: Interesting, illustrative examples of behavioral abnormalities in people with Parkinson's disease
Friedman, J. H., Akbar, U., Beehler, B., Chou, K. L., Cloud, L. J., Deik, A., Gilbert, R., Gomperts, S. N., Goudreau, J. L., Gunzler, S. A., Lizarraga, K., Malaty, I., Maurer, C. W., Miyasaki, J., Mohammed, N., Morgan, J. C., Munhoz, R. P., Pal, G., Shulman, L. & Simon, D. & 1 others, , May 1 2026, In: Arquivos de Neuro-Psiquiatria. 84, 5, s00461822631.Research output: Contribution to journal › Article › peer-review
Open Access -
ENLITE PD: A Randomized Clinical Trial of Light Therapy for Impaired Sleep in Parkinson's Disease
NeuroNEXT NN110 ENLITE PD Investigators, Nov 2025, In: Movement Disorders. 40, 11, p. 2445-2456 12 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Impact of COVID-19 on long-term outcomes in Parkinson's disease
Hadidchi, R., Al-Ani, Y., Piskun, H., Pakan, R., Duong, K. S., Jamil, H., Wang, S. H., Henry, S., Maurer, C. W. & Duong, T. Q., May 2025, In: European Journal of Neurology. 32, 5, e70013.Research output: Contribution to journal › Article › peer-review
Open Access12 Scopus citations -
Recognising and managing functional neurological disorder in the acute healthcare setting
Galenchik-Chan, A., Ren, T., Cohen, D. & Maurer, C. W., Nov 2025, In: Emergency Medicine Journal. 42, 11, p. 758-763 6 p.Research output: Contribution to journal › Review article › peer-review
3 Scopus citations